Table of Contents
Licensing
| Novartis Licenses Mesoblast’s Stem Cell Therapy Remestemcel-L | Abstract pdf html |
| Michelle Liu |
Mergers & Acquisitions
| Merck & Co. Continues Oncology Expansion with US$2.75 B VelosBio Buy | Abstract pdf html |
| Michelle Liu |
| Novo Nordisk Acquires Emisphere’s Eligen® Technology for US$1.8 B | Abstract pdf html |
| Michelle Liu |
This work is licensed under a Creative Commons Attribution 3.0 License.